Literature DB >> 17623744

Feasibility of nationwide birth registry control selection in the United States.

Logan G Spector1, Julie A Ross, Susan E Puumala, Michelle Roesler, Andrew F Olshan, Greta R Bunin.   

Abstract

As random digit dialing becomes increasingly unfeasible for many types of studies, alternative methods for control selection are needed, especially for studies of childhood cancer. US birth registries are an appealing source of young control children because they are population based, provide demographic and pregnancy data for comparison of participants with the study base, and maintain data that enable matching on birth characteristics. Here the authors describe the ability of US birth registries to release information sufficient to locate potential control subjects for two ongoing case-control studies of hepatoblastoma and infant leukemia. The birth registries of 32 states, in which 75.8% of US children 0-5 years of age resided in 2004, agreed to participate in control selection. Data sufficient to track participants and to characterize nonrespondents were available from a majority of registries. These results suggest that birth registries may be used to select controls for studies of rare childhood diseases on a national scale.

Entities:  

Mesh:

Year:  2007        PMID: 17623744     DOI: 10.1093/aje/kwm143

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Susan E Puumala; Julie A Ross; James H Feusner; Gail E Tomlinson; Marcio H Malogolowkin; Mark D Krailo; Logan G Spector
Journal:  Hum Reprod       Date:  2012-04-03       Impact factor: 6.918

2.  Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology Group.

Authors:  Amanda E Janitz; Gurumurthy Ramachandran; Gail E Tomlinson; Mark Krailo; Michaela Richardson; Logan Spector
Journal:  J Expo Sci Environ Epidemiol       Date:  2017-03-08       Impact factor: 5.563

3.  Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group.

Authors:  Lucie M Turcotte; Michael K Georgieff; Julie A Ross; James H Feusner; Gail E Tomlinson; Marcio H Malogolowkin; Mark D Krailo; Nicole Miller; Rachel Fonstad; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2014-07-15       Impact factor: 3.167

Review 4.  Children's Oncology Group's 2013 blueprint for research: epidemiology.

Authors:  Logan G Spector; Julie A Ross; Andrew F Olshan
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

5.  Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

Authors:  Rajkumar Venkatramani; Logan G Spector; Michael Georgieff; Gail Tomlinson; Mark Krailo; Marcio Malogolowkin; Wendy Kohlmann; Karen Curtin; Rachel K Fonstad; Joshua D Schiffman
Journal:  Am J Med Genet A       Date:  2014-06-16       Impact factor: 2.802

6.  To match or not to match in epidemiological studies--same outcome but less power.

Authors:  Tomas Faresjö; Ashild Faresjö
Journal:  Int J Environ Res Public Health       Date:  2010-01-26       Impact factor: 3.390

7.  Comparability and representativeness of control groups in a case-control study of infant leukemia: a report from the Children's Oncology Group.

Authors:  Susan E Puumala; Logan G Spector; Leslie L Robison; Greta R Bunin; Andrew F Olshan; Amy M Linabery; Michelle A Roesler; Cindy K Blair; Julie A Ross
Journal:  Am J Epidemiol       Date:  2009-06-04       Impact factor: 4.897

8.  Cancer Progress and Priorities: Childhood Cancer.

Authors:  Philip J Lupo; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06       Impact factor: 4.090

9.  Predictors of mother and child DNA yields in buccal cell samples collected in pediatric cancer epidemiologic studies: a report from the Children's Oncology group.

Authors:  Jenny N Poynter; Julie A Ross; Anthony J Hooten; Erica Langer; Crystal Blommer; Logan G Spector
Journal:  BMC Genet       Date:  2013-08-12       Impact factor: 2.797

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.